ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

PRESS RELEASE

published on 06/20/2025 at 19:30, 7 months 17 days ago

OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale dans la transparence, la sérénité des débats, et le respect des règles de marché
OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale dans la transparence, la sérénité des débats et le respect des règles de marché. La société publie un document 'Questions-Réponses' pour informer ses actionnaires

Assemblée Générale Transparence OSE Immunotherapeutics Questions-Réponses Règles De Marché
BRIEF

published on 06/19/2025 at 15:58, 7 months 18 days ago

Strategic change within OSE Immunotherapeutics

Board Of Directors General Meeting Crossing Thresholds OSE Immunotherapeutics Shareholders' Agreement
BRIEF

published on 06/19/2025 at 15:58, 7 months 18 days ago

Changement stratégique au sein d'OSE Immunotherapeutics

Assemblée Générale Conseil D'administration Franchissement De Seuils OSE Immunotherapeutics Pacte D'actionnaires
PRESS RELEASE

published on 06/19/2025 at 15:53, 7 months 18 days ago

Franchissement de seuils et déclaration d'intention
Déclaration de franchissement de seuils, déclaration d'intention et convention d'actionnaires de OSE Immunotherapeutics. Détails sur les actions et droits de vote

Franchissement De Seuils Action De Concert OSE Immunotherapeutics Déclaration D'intention Pacte D'actionnaires
BRIEF

published on 04/30/2025 at 07:35, 9 months 8 days ago

OSE Immunotherapeutics présente une nouvelle signature d'expression génique à l'AACR 2025

Immuno-oncologie Blocage Du Point De Contrôle Immunitaire Signature D'expression Génétique Traitement Personnalisé Prédiction Du Cancer
BRIEF

published on 04/30/2025 at 07:35, 9 months 8 days ago

OSE Immunotherapeutics Presents New Gene Expression Signature at AACR 2025

Immuno-oncology Personalized Treatment Immune Checkpoint Blockade Gene Expression Signature Cancer Prediction
PRESS RELEASE

published on 04/30/2025 at 07:30, 9 months 8 days ago

Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
OSE Immunotherapeutics and Léon Bérard Cancer Center present a new gene expression signature for predicting clinical response to immune checkpoint at AACR Annual Meeting 2025

AACR Annual Meeting OSE Immunotherapeutics Gene Expression Signature Léon Bérard Cancer Center Clinical Response Prediction
BRIEF

published on 04/09/2025 at 07:35, 9 months 29 days ago

OSE Immunotherapeutics présentera des données sur le lusvertikimab au DDW 2025

Rectocolite Hémorragique OSE Immunotherapeutics Lusvertikimab DDW 2025 Extension De La Phase 2
BRIEF

published on 04/09/2025 at 07:35, 9 months 29 days ago

OSE Immunotherapeutics to Present Data on Lusvertikimab at DDW 2025

Ulcerative Colitis OSE Immunotherapeutics Lusvertikimab Phase 2 Extension DDW 2025
PRESS RELEASE

published on 04/09/2025 at 07:30, 9 months 29 days ago

OSE Immunotherapeutics présentera des données inédites de la période d’extension de Lusvertikimab à la “Digestive Disease Week” (DDW) 2025
OSE Immunotherapeutics présentera des données inédites de la période d’extension de Lusvertikimab à la Digestive Disease Week (DDW) 2025

Rectocolite Hémorragique OSE Immunotherapeutics Lusvertikimab Anticorps Monoclonal Efficacité Et Sécurité

Accesswire

Published on 02/07/2026 at 01:00, 1 day 11 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 13 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 14 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 21 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 23 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 15 hours 57 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 20 hours 22 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 20 hours 37 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 17 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 19 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 18 hours ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 18 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 20 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 20 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 5 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE